Veronique Amor-Baroukh
Directeur des opérations chez ENLIVEX THERAPEUTICS LTD.
Provenance du réseau au premier degré de Veronique Amor-Baroukh
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Veronique Amor-Baroukh via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| WELLS FARGO & COMPANY | Major Banks | Corporate Officer/Principal | |
Presstek LLC
 Presstek LLC Industrial MachineryProducer Manufacturing Presstek LLC supplies digital offset printing solutions for the printing and communications industries. Its solutions include commercial printers, in plants, packaging, digital, franchise printers, and mailing services. The firm also offers inkjet, commercial CTP, commercial plates, newspaper plates, workflow, conventional offset products, and finishing equipment. The company was founded by Lawrence A. Howard in 1987 and is headquartered in Hudson, CT. | Industrial Machinery | Corporate Officer/Principal | |
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
| MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MVC CAPITAL, INC. | Investment Managers | Founder | |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Executive Officer Director/Board Member | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Pluristem Ltd.
 Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Miscellaneous Commercial Services | General Counsel | |
| Yale University | College/University | Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| MY SIZE, INC. | Internet Software/Services | Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
| EPIZYME, INC. | Biotechnology | Director of Finance/CFO | |
Credit Suisse Financial Services (Israel) Ltd.
 Credit Suisse Financial Services (Israel) Ltd. Financial ConglomeratesFinance Credit Suisse Financial Services (Israel) Ltd. provides investment products and services. The company acts as a gateway to Credit Suisse's private banking, investment banking, and asset management businesses. It offers products and services including equities, bonds, mutual funds, structured products, and alternative investments. Credit Suisse Financial Services (Israel) was founded in 2007 and is headquartered in Tel Aviv, Israel | Financial Conglomerates | Corporate Officer/Principal | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| The College of Management Academic Studies | College/University | Masters Business Admin | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| QUICKLIZARD LTD | Packaged Software | Director/Board Member | |
| INNOVISION LABS, INC. | Packaged Software | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin | |
| J.F. Kapnek Trust | Director/Board Member | ||
| RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Pharmaceuticals: Major | Director/Board Member | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
| Janssen Therapeutics, Inc. | President | ||
Prolor Biotech Ltd.
 Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
| Pomerantz Life Sciences Consulting Group LLC | President | ||
| Lg Electronics (Israel) | Corporate Officer/Principal | ||
SpliSense Ltd.
 SpliSense Ltd. Pharmaceuticals: MajorHealth Technology SpliSense Ltd. engages in the development of targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease. The company was founded on November 10, 2016 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chief Executive Officer | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| Technion Institute | College/University | Undergraduate Degree | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 24 |
| Israël | 24 |
| Irlande | 2 |
| Roumanie | 2 |
| Îles Cayman | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 10 |
| Finance | 6 |
| Technology Services | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 39 |
| Corporate Officer/Principal | 17 |
| Independent Dir/Board Member | 17 |
| Chairman | 16 |
| Chief Executive Officer | 9 |
Relations les plus connectées
| Insiders | |
|---|---|
| Roger Pomerantz | 30 |
| Avri Havron | 14 |
| Shai Novik | 13 |
| Gili Hart | 11 |
| Brian Schwartz | 9 |
| Andrew Singer | 9 |
| Oren Elmaliah | 6 |
| Dror Mevorach | 4 |
| Shachar Shlosberger | 3 |
| Oren Hershkovitz | 3 |
| Einat Galamidi | 3 |
| Iris Tavor | 2 |
| Sigal Arad | 2 |
- Bourse
- Insiders
- Veronique Amor-Baroukh
- Connexions Sociétés